What does this research mean for the field?

Streptokinase, anistreplase, and tissue plasminogen activator (tPA) are viable fibrinolytic agents for the treatment of acute myocardial infarction. Novelty: ClaimNovelty.INCREMENTAL. Consensus alignment: ConsensusAlignment.NEUTRAL.

May 25, 1991Open Access

Battle of the clotbusters.

Key Points

Key points are not available for this paper at this time.

Abstract

Coordinated by Dr Rory Collins from Oxford, the data for the third international study of infarct survival (ISIS-3) came from investigators in nearly 1 000 hospitals in Europe, North America, and Australasia who had treated over 46 000 patients suffering an acute myocardial infarction with one of three randomly assigned fibrinolytic agents : streptokinase, anistreplase, or tissue plasminogen activator (tPA)

Bookmark

View Full Paper

Cite This Study

Martin O’Donnell (Sat,) studied this question.

synapsesocial.com/papers/6a15a0f679ff98d0de4ee9bd https://doi.org/https://doi.org/10.1136/bmj.302.6787.1259